These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 17255785

  • 1. Insight into the molecular pathogenesis of myeloid malignancies.
    Haferlach T, Bacher U, Haferlach C, Kern W, Schnittger S.
    Curr Opin Hematol; 2007 Mar; 14(2):90-7. PubMed ID: 17255785
    [Abstract] [Full Text] [Related]

  • 2. Molecular characterization of acute myeloid leukemia and its impact on treatment.
    Frankfurt O, Licht JD, Tallman MS.
    Curr Opin Oncol; 2007 Nov; 19(6):635-49. PubMed ID: 17906465
    [Abstract] [Full Text] [Related]

  • 3. Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.
    Falini B, Sportoletti P, Martelli MP.
    Curr Opin Oncol; 2009 Nov; 21(6):573-81. PubMed ID: 19770764
    [Abstract] [Full Text] [Related]

  • 4. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
    Mrózek K, Döhner H, Bloomfield CD.
    Curr Opin Hematol; 2007 Mar; 14(2):106-14. PubMed ID: 17255787
    [Abstract] [Full Text] [Related]

  • 5. The molecular pathogenesis of acute myeloid leukemia.
    Steffen B, Müller-Tidow C, Schwäble J, Berdel WE, Serve H.
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):195-221. PubMed ID: 16236521
    [Abstract] [Full Text] [Related]

  • 6. The role of HOX genes in myeloid leukemogenesis.
    Eklund EA.
    Curr Opin Hematol; 2006 Mar; 13(2):67-73. PubMed ID: 16456371
    [Abstract] [Full Text] [Related]

  • 7. Mutations of NPM1 gene in de novo acute myeloid leukaemia: determination of incidence, distribution pattern and identification of two novel mutations in Indian population.
    Ahmad F, Mandava S, Das BR.
    Hematol Oncol; 2009 Jun; 27(2):90-7. PubMed ID: 19365794
    [Abstract] [Full Text] [Related]

  • 8. [Abnormal expression of transcription factors LYL1 and LMO2 and interaction between them in myeloid leukemia].
    Meng YS, Wei R, Ai GW, Meng XQ, Zhang YX.
    Zhonghua Yi Xue Za Zhi; 2009 Apr 07; 89(13):890-3. PubMed ID: 19671288
    [Abstract] [Full Text] [Related]

  • 9. Retinoic acid receptors, hematopoiesis and leukemogenesis.
    Collins SJ.
    Curr Opin Hematol; 2008 Jul 07; 15(4):346-51. PubMed ID: 18536573
    [Abstract] [Full Text] [Related]

  • 10. Genomics in myeloid leukemias: an array of possibilities.
    Bullinger L, Döner H, Pollack JR.
    Rev Clin Exp Hematol; 2005 Jun 01; 9(1):E2. PubMed ID: 16027104
    [Abstract] [Full Text] [Related]

  • 11. New molecular concepts and targets in acute myeloid leukemia.
    Buzzai M, Licht JD.
    Curr Opin Hematol; 2008 Mar 01; 15(2):82-7. PubMed ID: 18300752
    [Abstract] [Full Text] [Related]

  • 12. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
    Baldus CD, Bullinger L.
    Semin Oncol; 2008 Aug 01; 35(4):356-64. PubMed ID: 18692686
    [Abstract] [Full Text] [Related]

  • 13. Retinoic acid signaling in myelopoiesis.
    Drumea K, Yang ZF, Rosmarin A.
    Curr Opin Hematol; 2008 Jan 01; 15(1):37-41. PubMed ID: 18043244
    [Abstract] [Full Text] [Related]

  • 14. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA, Dorn DC, Schuringa JJ, Chung KY, Morrone G.
    Exp Hematol; 2007 Apr 01; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [Abstract] [Full Text] [Related]

  • 15. Progress and strategies for patients with relapsed and refractory acute myeloid leukemia.
    Litzow MR.
    Curr Opin Hematol; 2007 Mar 01; 14(2):130-7. PubMed ID: 17255790
    [Abstract] [Full Text] [Related]

  • 16. Role of nucleophosmin in acute myeloid leukemia.
    Meani N, Alcalay M.
    Expert Rev Anticancer Ther; 2009 Sep 01; 9(9):1283-94. PubMed ID: 19761432
    [Abstract] [Full Text] [Related]

  • 17. Rapid screening and sensitive detection of NPM1 (nucleophosmin) exon 12 mutations in acute myeloid leukaemia.
    Scholl S, Mügge LO, Landt O, Loncarevic IF, Kunert C, Clement JH, Höffken K.
    Leuk Res; 2007 Sep 01; 31(9):1205-11. PubMed ID: 17306368
    [Abstract] [Full Text] [Related]

  • 18. CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.
    Fuchs O, Provaznikova D, Kocova M, Kostecka A, Cvekova P, Neuwirtova R, Kobylka P, Cermak J, Brezinova J, Schwarz J, Markova J, Salaj P, Klamova H, Maaloufova J, Lemez P, Novakova L, Benesova K.
    Blood Cells Mol Dis; 2008 Sep 01; 40(3):401-5. PubMed ID: 18182175
    [Abstract] [Full Text] [Related]

  • 19. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.
    Verhaak RG, Wouters BJ, Erpelinck CA, Abbas S, Beverloo HB, Lugthart S, Löwenberg B, Delwel R, Valk PJ.
    Haematologica; 2009 Jan 01; 94(1):131-4. PubMed ID: 18838472
    [Abstract] [Full Text] [Related]

  • 20. [Mutations of epigenetic regulator genes and myeloid malignancies].
    Muto T, Sashida G, Oshima M, Iwama A.
    Rinsho Ketsueki; 2015 Nov 01; 56(11):2287-94. PubMed ID: 26666714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.